NEWS

PRESS RELEASES

10.28.14
Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease

ARTICLES

10 Next-Gen Biologics Platforms: – FierceBiotech

EVENTS

11.10.14 – 11.12.14

10th Annual European Antibody Congress (David E. Szymkowski, Ph.D., presenting; Geneva, Switzerland)